19.9 Evidence Behind the Case

Time To Read

3–4 minutes

Date Last Modified

Module 19 is the chapter the whole course moves toward: protein in the urine, then nephrotic-range proteinuria, then a biopsy showing AA amyloid in the glomeruli. Renal amyloidosis is what turns FMF from painful to life-threatening — and adherent colchicine is what prevents it.

This page belongs to a teaching case built around familial Mediterranean fever (FMF), an IL-1β-driven autoinflammatory disease. If you found it searching a renal finding — for a patient — it is a valid, evidence-anchored starting point, and it is urgent.

Jump to it:

A routine urinalysis showed protein; a quantified sample returned nephrotic-range proteinuria; a renal biopsy confirmed what years of untreated serum amyloid A had predicted — AA amyloid deposited in her glomeruli. ‘A little protein — recheck it sometime.’ Module 19 reads proteinuria as the alarm it is. Stina is me.

Renal AA amyloidosis is the defining, most serious complication of untreated FMF, presenting as proteinuria/nephrotic syndrome and progressing to renal failure.1,2 Circulating SAA is the precursor and predicts outcome.5 The finding that reframed the disease: lifelong colchicine prevents amyloidosis and protects the kidney,3 and can stabilize established amyloid nephropathy.4 Amyloid breaks the glomerular filtration barrier that normally holds albumin back.6 (general renal physiology).

If you reached this page searching persistent or nephrotic-range proteinuria of unclear cause, or renal AA amyloidosis, that is the page doing its job — and it matters: proteinuria in an FMF patient is not a trace to recheck later. It is the alarm, and adherent colchicine is the answer.

CHART CLUE #17

Nephrotic proteinuria with biopsy-proven AA amyloid, after years of high SAA, is renal amyloidosis — the defining FMF complication — demanding aggressive treatment, not a benign trace finding.

THE CLIMAX

Renal AA amyloidosis progresses proteinuria → nephrotic syndrome → renal failure; it is the FMF complication that is life-threatening.

TREATMENT

Lifelong colchicine lowers SAA, preventing amyloidosis and preserving renal function — and can stabilize established amyloid nephropathy.

GLOMERULUS

Amyloid disrupts the glomerular filtration barrier that normally retains albumin, producing glomerular proteinuria.

Stina is not a composite. Stina is me. The ‘little protein, recheck it sometime’ was mine — and it was the alarm that everything before it had been building toward. This is the chapter I most need a clinician to read in time for someone else.

This page holds both truths at once. The lived experience is real; the research support is what earns the case a place in a science course, and the general renal-physiology step is flagged. If you are a clinician who arrived from a patient: proteinuria in FMF is urgent — quantify it, and protect the kidney with adherent colchicine.

Recurrent peritonitis & amyloid — Chart Clue #15.

The chemistry follows the kidney — Chart Clue #18.

Five rashes, one fire — the skin as billboard.

One gene behind twenty clues — Chart Clue #20.

List of terms